CAS No.:138-85-2
Name: Sodium 4-hydroxymercuriobenzoate
Details Introduction
TOXICITY DATA with REFERENCE：
| 1. |
sln-mold-asn 8 µmol/L |
MUREAV Mutation Research. 178 (1987),33. | ||
| 2. |
ipr-rat LD50:4960 µg/kg |
JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. 36 (1947),30. |
Consensus Reports：
Mercury and its compounds are on the Community Right-To-Know List. Reported in EPA TSCA Inventory.
SAFETY PROFILE：
Poison by intraperitoneal route. Mutation data reported. When heated to decomposition it emits toxic fumes of Hg and Na2O. See also MERCURY COMPOUNDS, INORGANIC; MERCURY COMPOUNDS, ORGANIC.Safety information of Sodium 4-hydroxymercuriobenzoate (CAS NO.138-85-2):
Hazard Codes 
T+,
N
Risk Statements
26/27/28 Very Toxic by inhalation, in contact with skin and if swallowed
33 Danger of cumulative effects
50/53 Very Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment
Safety Statements
13 Keep away from food, drink and animal feeding stuffs
28 After contact with skin, wash immediately with plenty of ... (to be specified by the manufacturer)
36 Wear suitable protective clothing
45 In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
60 This material and/or its container must be disposed of as hazardous waste
61 Avoid release to the environment. Refer to special instructions safety data sheet
RIDADR UN 2025 6.1/PG 2
WGK Germany 3
RTECS OV8150000
F 3-10
HazardClass 6.1(a)
PackingGroup II
Standards and Recommendations：
OSHA PEL: CL 0.1 mg(Hg)/m3 (skin)
ACGIH TLV: TWA 0.1 mg(Hg)/m3 (skin); BEI: 35 µg/g creatinine total inorganic mercury in urine preshift; 15 µg/g creatinine total inorganic mercury in blood at end of shift at end of workweek.
DFG MAK: Confirmed Animal Carcinogen with Unknown Relevance to Humans
NIOSH REL: (Mercury, Aryl and Inorganic) CL 0.1 mg/m3 (skin)
Analytical Methods：
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione